Sensei Biotherapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- January 13, 2021
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $30,000,000
Company Info
- Founders
- John Celebi
- Company Description
- Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation of immunotherapies for the treatment of cancer and infectious diseases. The company has developed a proprietary phage-based platform, ImmunoPhage, that enables the rapid generation of immune activating agents that fully engage the immune system.
- Market
- Cancer and infectious diseases
- Location
- Rockville, MD, USA
- Coinvestors
- Apeiron Investment Group, Cambrian Biopharma, Catalio Capital Management, Future Ventures, Moore Strategic Ventures, Presight Capital, Pura Vida Investments